|
1
|
Zic JA: Lymphomatoid papulosis treatment
& management. Medscape Website. Available at: http://emedicine.medscape.com/article/1098954-treatmenturi.
Accessed January 24, 2012
|
|
2
|
Fernández-Guarino M, Carrillo-Gijón R and
Jaén-Olasolo P: Lymphomatoid papulosis: clinical and pathological
findings in 18 patients. Actas Dermosifiliogr. 103:388–393.
2012.(In Spanish).
|
|
3
|
Martorell-Calatayud A, Hernández-Martín A,
Colmenero I, et al: Lymphomatoid papulosis in children: report of 9
cases and review of the literature. Actas Dermosifiliogr.
101:693–701. 2010.(In Spanish).
|
|
4
|
Magro CM and Crowson AN: CD30-positive
lymphoproliferative disorders including lymphomatoid papulosis,
borderline CD3-positive lymphoproliferative disease, anaplastic
large cell lymphoma, and T-cell-rich CD30-positive large B cell
lymphoma. The Cutaneous Lymphoid Proliferations: A Comprehensive
Textbook of Lymphocytic Infiltrates of the Skin. Magro CM, Crowson
AN and Mihm MC: John Wiley & Sons, Inc; Hoboken, NJ: pp.
440–444. 2007
|
|
5
|
Macaulay WL: Lymphomatoid papulosis. A
continuing self-healing eruption, clinically benign -
histologically malignant. Arch Dermatol. 97:23–30. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Willemze R, Jaffe ES, Burg G, et al:
WHO-EORTC classification for cutaneous lymphomas. Blood.
105:3768–3785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Willemze R and Meijer CJ: Classification
of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutan
Pathol. 33(Suppl 1): 18–26. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Slater DN: The new World Health
Organization-European Organization for Research and Treatment of
Cancer classification for cutaneous lymphomas: a practical marriage
of two giants. Br J Dermatol. 153:874–880. 2005. View Article : Google Scholar
|
|
9
|
de Souza A, el-Azhary RA, Camilleri MJ,
Wada DA, Appert DL and Gibson LE: In search of prognostic
indicators for lymphomatoid papulosis: a retrospective study of 123
patients. J Am Acad Dermatol. 66:928–937. 2012.PubMed/NCBI
|
|
10
|
Laube S, Stephens M, Smith AG, et al:
Lymphomatoid papulosis in a patient with atopic eczema on long-term
ciclosporin therapy. Br J Dermatol. 152:1346–1348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leo AM and Ermolovich T: Lymphomatoid
papulosis while on efalizumab. J Am Acad Dermatol. 61:540–541.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JH, Lee J, Lee JH, et al:
Lymphomatoid papulosis in a patient treated with adalimumab for
juvenile rheumatoid arthritis. Dermatology. 225:259–263. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim SK and Kim YC: Lymphomatoid papulosis
after allogenic stem cell transplantation. Eur J Dermatol.
19:520–521. 2009.PubMed/NCBI
|
|
14
|
Atkins KA, Dahlem MM and Kohler S: A case
of lymphomatoid papulosis with prominent myxoid change resembling a
mesenchymal neoplasm. Am J Dermatopathol. 25:62–65. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Van Neer FJ, Toonstra J, Van Voorst Vader
PC, et al: Lymphomatoid papulosis in children: a study of 10
children registered by the Dutch Cutaneous Lymphoma Working Group.
Br J Dermatol. 144:351–354. 2001.PubMed/NCBI
|
|
16
|
Chen L, Jin HZ, Yin HL, et al:
Lymphomatoid papulosis. Study on the prevention and treatment of
tumor. Zhong Liu Fang Zhi Yan Jiu. 27:130–132. 2000.(In
Chinese).
|
|
17
|
Willemze R, Meyer CJ, Van Vloten WA and
Scheffer E: The clinical and histological spectrum of lymphomatoid
papulosis. Br J Dermatol. 107:131–144. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Querfeld C, Kuzel TM, Guitart J and Rosen
ST: Primary cutaneous CD30+ lymphoproliferative
disorders: new insights into biology and therapy. Oncology
(Willston Park). 21:689–696; discussion 699–700. 2007.
|
|
19
|
Heald P, Subtil A, Breneman D and Wilson
LD: Persistent agmination of lymphomatoid papulosis: an equivalent
of limited plaque mycosis fungoides type of cutaneous T-cell
lymphoma. J Am Acad Dermatol. 57:1005–1011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shao Z, Zuo C, Ge L, et al: Lymphomatoid
papulosis: Case report and literature review. Wei Xun Huan Xue Za
Zhi. 22:34–36. 2012.(In Chinese).
|
|
21
|
Saggini A, Gulia A, Argenyi Z, et al: A
variant of lymphomatoid papulosis simulating primary cutaneous
aggressive epidermotropic CD8+ cytotoxic T-cell
lymphoma: Description of 9 cases. Am J Surg Pathol. 34:1168–1175.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El Shabrawi-Caelen L, Kerl H and Cerroni
L: Lymphomatoid papulosis: reappraisal of clinicopathologic
presentation and classification into subtypes A, B, and C. Arch
Dermatol. 140:441–447. 2004.PubMed/NCBI
|
|
23
|
Liao QL, Chen XD, Wang W, et al: The
clinical pathological analysis of primary cutaneous
CD30+ lymphoproliferative disease. Zhong Hua Pi Fu Ke Za
Zhi. 44:151–154. 2011.(In Chinese).
|
|
24
|
Andersen RM, Larsen MS, Poulsen TS, et al:
Lymphomatoid papulosis type D or an aggressive epidermotropic
CD8(+) cytotoxic T-cell lymphoma? Acta Derm Venereol. 94:474–475.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sim JH and Kim YC: CD8+ lymphomatoid
lapulosis. Ann Dermatol. 23:104–107. 2011. View Article : Google Scholar
|
|
26
|
Hoetzenecker W, Guenova E, Hoetzenecker K,
et al: Successful treatment of recalcitrant lymphomatoid papulosis
in a child with PUVA-bath photochemotherapy. Eur J Dermatol.
19:646–647. 2009.PubMed/NCBI
|
|
27
|
Coelho JD, Afonso A and Feio AB: Regional
lymphomatoid papulosis in a child - treatment with a UVB
phototherapy handpiece. J Cosmet Laser Ther. 12:155–156. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rodrigues M, McCormack C, Yap LM, et al:
Successful treatment of lymphomatoid papulosis with photodynamic
therapy. Australas J Dermatol. 50:129–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yip L, Darling S and Orchard D:
Lymphomatoid papulosis in children: experience of five cases and
the treatment efficacy of methotrexate. Australas J Dermatol.
52:279–283. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang SX, Chen H, Sun JF and Xu XL:
Regional lymphomatoid papulosis successfully controlled by
interferon α-2b and nitrogen mustard solution. Chin Med J (Engl).
126:3194–3195. 2013.PubMed/NCBI
|
|
31
|
Spires N and McGibbon D: Lymphomatoid
papulosis improving on hormone-replacement therapy. Clin Exp
Dermatol. 34:635–636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grange F and Bagot M: Prognosis of primary
cutaneous lymphomas. Ann Dermatol Venereol. 129:30–40. 2002.(In
French).
|
|
33
|
Nijsten T, Curiel-Lewandrowski C and Kadin
ME: Lymphomatoid papulosis in children: a retrospective cohort
study of 35 cases. Arch Dermatol. 140:306–312. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kunishige JH, McDonald H, Alvarez G,
Johnson M, Prieto V and Duvic M: Lymphomatoid papulosis and
associated lymphomas: a retrospective case series of 84 patients.
Clin Exp Dermatol. 34:576–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bekkenk MW, Geelen FA, van Voorst Vader
PC, et al: Primary and secondary cutaneous CD30(+)
lymphoproliferative disorders: a report from the Dutch Cutaneous
Lymphoma Group on the long-term follow-up data of 219 patients and
guidelines for diagnosis and treatment. Blood. 95:3653–3661.
2000.PubMed/NCBI
|
|
36
|
Beljaards RC and Willemze R: The prognosis
of patients with lymphomatoid papulosis associated with malignant
lymphomas. Br J Dermatol. 126:596–602. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan AW and Giam YC: Lymphomatoid papulosis
associated with recurrent cutaneous T-cell lymphoma. Ann Acad Med
Singapore. 33:110–112. 2004.PubMed/NCBI
|
|
38
|
Rosen ST and Querfild C: Primary cutaneous
T-cell lymphomas. Hematology Am Soc Hematol Educ Program.
2006:323–330. 2006. View Article : Google Scholar
|
